CCM
TEVA icon

Cutter Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Cutter Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-801,806
Closed -$12.3M – 20
2025
Q1 		$12.3M Buy
801,806
+216,923
+37% +$3.87M 5.37% 10
2024
Q4 		$12.9M Buy
+584,883
New +$10.6M 5.28% 9
2024
Q3 		– Sell
-911,900
Closed -$14.8M – 39
2024
Q2 		$14.8M Sell
911,900
-223,810
-20% -$3.45M 4.47% 11
2024
Q1 		$16M Buy
1,135,710
+74,042
+7% +$933K 6.13% 3
2023
Q4 		$11.1M Buy
+1,061,668
New +$9.91M 5.3% 8

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Cutter Capital Management's TEVA Position: Q2 2025 in Review

Cutter Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2025, closing a stake of 801,806 shares — an estimated $12.3M sold.

Cutter Capital Management first reported a position in TEVA in Q4 2023 and held it in 5 quarters. The position peaked at $16M in Q1 2024. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2025.

  • Cutter Capital Management reported no remaining Teva Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Cutter Capital Management sold 801,806 Teva Pharmaceuticals shares in Q2 2025, an estimated $12.3M.
  • Cutter Capital Management first reported a position in Teva Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • Cutter Capital Management's Teva Pharmaceuticals position peaked at $16M in Q1 2024.
  • 539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2025.

Based on Cutter Capital Management's 13F filing for Q2 2025.